The present status of management of carcinoma of the body of the uterus was discussed at this meeting, including both diagnostic and therapeutic aspects.
Dr G Cherryman (Royal Marsden Hospital and Institute of Cancer Research, Sutton) discussed the use of ultrasound, CT scanning and nuclear magnetic resonance <NMR) in the preoperative staging of these tumours. Although ultrasound does help in evaluation of these tumours, it suffers from a lack of reliability for predicting myometrial invasion and it makes no contribution towards diagnosing cervical involvement. A dynamic CT scan on the other hand can predict myometrial invasion of more than 50% of its thickness and cervical extension with a high degree of accuracy ranging from 85% to 90%1,2. CT scanning can also detect parametrial invasion with nearly 80% accuracy.
NMR gives better images than CT scanning due to higher contrast. In an NMR scan, the cervix is clearly distinguishable from the body of the uterus and hence extension of the endometrial tumour into the cervix can be detected with a fair degree of accuracy. NMR would therefore be particularly helpful in cases where fractional curettage has failed to detect cervical invasion. Disruption of the low-intensity junctional zone in the endometrium may help in detecting small tumours, but this zone is seen only in young patients who are not taking oral contraceptives. Fibroids can also be clearly distinguished from tumours in an NMR scan. An NMR scan can detect parametrial invasion and is better than a CT scan for delineating uterine size.
Early detection oflymphatic spread is an important factor in the management of carcinoma of the body of the uterus, and treatment often fails due to unsuspected nodal disease in the pelvis and/or paraaortic nodes. A CT scan can detect para-aortic nodes with 90-95% accuracy, but for pelvic nodes its accuracy falls to about 70%. While a CT scan is better than NMR for detecting nodal disease in the abdomen, for pelvic nodes NMR is superior. Lymphangiography is still an important method of detecting pelvic and para-aortic lymph nodes, with an overall accuracy of about 87%.
Thus a CT scan (and NMR when indicated) should be done in patients with carcinoma of the body of the uterus before any treatment; this can both delineate tumour volume and nodal disease, help in radiotherapy planning, and aid in assessing response to treatment and detection of early recurrence.
Dr Roger King (Imperial Cancer Research Fund, London) gave an overview of hormonal treatment of endometrial carcinoma. Over the years progestins have been the mainstay of hormonal treatment and act by inhibiting oestrogen-aided DNA synthesis.
Hormonal treatment of endometrial carcinoma has special advantage since tissue is usually available for evaluating the effect of progestins both before and after treatment.
Distribution of receptor phenotypes of endometrial carcinoma studed in 252 patients was found to be:
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In spite of the presence of receptors for both oestrogens and progestins in about 70% of the cases, this did not correlate well with the clinical response. To explain the discrepancy, change in oestrogen receptor phenotype after treatment with medroxyprogesterone acetate was studied in 23 patients. Of 16 patients with RE+ phenotype, 15 showed change with treatment, and only these patients were expected to show a clinical response. One patient in the RE+ group showed no change and 7 patients were RE-ve.
In 1980 Pallow et al. 3 studied the degree of histological effect in the endometrium after treatment with medroxypyrogesterone acetate and tried to correlate it with clinical response. On histological and cytological evidence the majority of patients seemed to show response but it did not correlate with clinical response, which was much lower than expected. Later it was found that only a 'strong' histological effect corresponded with good clinical response; clinical response was poor where histological effect was dubious or absent. Progestins seem to act best in a high oestrogen environment, but most patients with endometrial carcinoma are postmenopausal. This may explain the poor response to hormones in these patients. To increase oestrogen levels, oral oestrogens (which have ethical difficulties!) or anti-oestrogens like tamoxifen can be tried. Another factor affecting clinical response is the dose of progestins given. Richardson and Macl.aughlin! obtained a dose-response relationship for Provera from various reports in the literature. Maximum response of the order of 50% was observed when the dose of Provera was 1-2 g per week.
Besides these, other factors which need consideration in evaluating hormonal treatment are tumour cell proliferation rate, tumour invasiveness, metastatic potential, chemosensitivity and differentiation.
Radiotherapeutic aspects of the management of endometrial carcinoma were discussed by Dr Thelma Bates (St Thomas' Hospital, London). She presented the follow-up (minimum 5 years) of 396 patients with Stage I endometrial carcinoma treated during the period 1945-1981. All patients had surgery and/or radiotherapy in one form or another. During this period, radiotherapy underwent many technological advances. Radium and orthovoltage X-rays were the main modalities of treatment during the period 1945-56, changing to cobalt-60teletherapy in 1957 and finally to megavoltage X-rays from a linear accelerator and high-dose rate intracavitary irradiation with the Cathetron in 1970. Table 1 shows the distribution of patients according to treatment received. All patients had surgery Table 2 . Five-yearsurvival ofpatients with StageI endometrial carcinoma according to depth of myometrial invasion consisting of total abdominal hysterectomy and bilateral salpingo-oophorectomy with a generous vaginal cuff. Preoperative intracavitary radium consisted of an intrauterine tube delivering a dose of 60 Gy at 1 em, while with an intrauterine tube and two vaginal ovoids a dose of 60 Gy was delivered to Point A. Postoperative vaginal vault irradiation delivered a dose of 50 Gy at 0.5 em to the upper third of the vagina. High-dose rate intracavitary Cathetron treatment consisted of delivering 21 Gy at 0.5 em over 2 days. Postoperative external radiotherapy was given by 4-field 'brick' technique delivering a tumour dose of 42 Gy/12fractions/28 days. Patients included in this series had Stage I adenocarcinoma confined to the corpus uteri and were classified as: superficial (< onethird) or no myometrial invasion, deep myometrial invasion and/or involvement of the isthmus. Tables 2 and 3 show 5-year survival versus depth of myometrial invasion and treatment received. As expected, patients with superficial myometrial invasion fared better than patients with deep myometrial invasion. However, the overall results are more or less the same as during the last 30 years despite rapid technological advances in radiotherapy and surgery. The issue of radiation before or after surgery did not make any distinct change in overall survival except that the best results were seen in patients who, received postoperative external radiation. Vault recurrence was another problem which was highlighted. It correlated with the depth of myometrial invasion and was seen in about 2.5% of patients with superficial invasion and 4% with deep invasion. This incidence has also remained unchanged over the last 30 years. The only patients who did not suffer vault recurrence were those who received postoperative external radiotherapy.
The grade of the tumour and depth of myometrial invasion were found to be the most important prognostic factors. In Grade G 2 and G s tumours with or without deep myometrial invasion, best results were seen in the surgery and external radiotherapy group. There was argument against preoperative intracavitary radiation since it does not help in improving vault recurrence, it distorts the pathological specimen needed for delineating the extent of the disease and delays surgery. Patients with G 1 tumour and superficial myometrial invasion do not need postoperative irradiation.
In an effort to improve results further, the need for nodal dissection was considered, but it could mean unnecessary surgery in node-negative patients and increased morbidity. A strong need was felt to improve the existing imaging techniques (as discussed by Dr Cherryman) so that treatment could be individualized according to the exact extent of disease, which would hopefully lead to further improvement in the results.
Surgical management ofendometrial carcinoma was discussed by MrJohn Hartgill (The London Hospital). He emphasized the need to look into reasons for failure in about 15-20% of patients with apparently Stage I carcinoma of the body of the uterus, since it has remained virtually unchanged over the last 30 years. Two-thirds of patients with positive nodes (pelvic and/or para-aortic) die within 5 years. He therefore started a study of lymphangiography in patients with endometrial carcinoma. He found that in a few patients the para-aortic nodes could be the first nodes to be involved, hence no cancer surgery could have been curative in these patients unless these nodes (first echelon) were removed. He used chlorophyll in the lymphangiography so that greencoloured lymphatic vessels and nodes could be identified and dissected thoroughly. In spite of these efforts, at nodal dissection in one of the patients, 14 nodes were left behind which were seen in the X-ray taken after surgery. Thorough dissection of lymphatic vessels was found to be as important as removal of lymph nodes since lymphatic vessels often contained tumour emboli. Direct permeation of tumour emboli was also noticed from the body of the uterus to the vaginal vault. Therefore he advocated modification in surgical treatment which should involve Wertheim's hysterectomy preceded by intracavitary radiation.
During the years 1961-80, 631 patients with carcinoma of the body of the uterus were treated at the London Hospital with an overall survival of 80%. In his personal series of 136 patients treated during the years 1964-85, 85 patients had Stage I, 43 Stage II and 8 Stage III and IV tumours; 24.2% of the patients had positive nodes detected by lymphangiography. In 8 patients, nodes containing tumour 'left behind' after Wertheim's hysterectomy were detected in the X-ray taken on the operating table and subsequently removed. Seven patients (5%)died of the disease and 6 suffered local recurrence. In 14 patients, the operation had to be abandoned due to excessive haemorrhage, obesity, etc. There was no increased morbidity and no patient developed fistula after Wertheim's hysterectomy. In this regard he advocated utmost care to save the autonomic nervous system, which would reduce the risk of bladder injury.
Wertheim's hysterectomy was done within 36-42 hours ofpreoperative irradiation to reduce the chances of haemorrhage due to adhesions. Postoperative radiotherapy was delivered only in patients with positive nodes, deep myometrial invasion and Grade II and III tumours. No advantage was observed with the use of progestins as an adjuvant treatment in this series.
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Purpose of the protocol
The first speaker, Mr Paul Vinall (Consultant Obstetrician, Leeds General Infirmary), described the evolution, under his guidance, of a birth protocol at the Maternity Unit of the Leeds General Infirmary. Up to the time of his appointment, maternity care in the unit had been largely in the hands of the midwives, who determined most of its 'events' by deciding when medical aid should be called, and expected medical practitioners to conform to a rigidly conservative style of management. Following Mr Vinall's appointment in 1980 as consultant obstetrician with special responsibility for the labour ward, a series of meetings took place amongst the staff, at consultant level, from which there emerged a consensus on birth management issues, particularly in abnormal clinical circumstances. The resultant document had, he felt, played a small but crucial part in changing the style of obstetric practice within the hospital. Mr Vinall maintained that the Leeds protocol represented a set of guidelines which did not require rigid and unthinking adherence, but allowed for individual initiative and thoughtful care. The advantage of its use was to encourage consistency in practice and a yardstick against which future developments could be assessed.
During the period of time over which the protocol had evolved, some interesting and encouraging changes had occurred. There had been a fall in the induction rate from 23% in 1980 to 6.1% in 1985. The number of normal deliveries had increased (from 63.2% to 70%), while the numberofforceps deliveries had declined (from 19.1% to 14.4%); 50% of women delivering in the unit had epidurals and 12% had caesarean sections. Mr Vinall maintained that the introduction of routine electronic fetal monitoring had virtually eliminated intrapartum deaths from asphyxia.
Birth plans
The Forum's second speaker, Sheila Kitzinger (social anthropologist and childbirth educator, Oxford), highlighted differences between traditional cultures and western industrial societies, such as our own. In the former, women largely maintained and controlled the processes surrounding childbirth, where every action was part of a prearranged plan, implicit and understood by everyone, and the traditional rituals reflected the value the society attached to the biophysical functions of its women at any stage of their lives. In our own society, men tended to exert the controlling influence and birth had become a medicosurgical process, with child-bearing women playing relatively little part in obstetric plans.
In response to the present situation, many women in the UK were now formulating their own birth plans; at their most basic, such plans consisted of a series of instructions to care-givers to abstain from intervention. Such an approach might serve only to arouse the resentment of care-givers, but circumstances might prevent the potential for birth plans to become the focus for the development of interaction and mutual education of the woman and her helpers from being realized. Mrs Kitzinger was also critical of some 'hospital-generated' birth plans, which, far from offering women a real choice, sought to assert the power of the institution by defining and limiting the parameters of choice (e.g, presenting a restrictive 'menu' of choices).
Properly understood, the birth plan should, she maintained, be seen as a process (not a one-offevent) arising from the wishes and feelings of the pregnant woman, assisted by the small group of midwives caring for her. Such plans were best couched in general (but not vague) terms 80 as not to circumscribe
